News from oligomerix, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 30, 2014, 10:17 ET

Oligomerix, Inc. to Present its Drug Discovery Program Targeting Tau Oligomers at the Federation of European Neuroscience Societies Forum and the Alzheimer's Association International Conference®

 Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and...

Jan 14, 2014, 10:17 ET

Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College

 Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and...

Jan 07, 2014, 10:17 ET

Oligomerix to Present at Biotech Showcase™ 2014

 Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and...

Sep 10, 2013, 10:17 ET

Oligomerix Awarded Phase IIB Grant From the NIH to Discover Drugs that Inhibit Alzheimer's Disease Progression

 Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and...

Sep 04, 2013, 11:06 ET

Identification of a Tau Oligomer Structure That is Toxic to Neurons Published in the International Journal of Cell Biology

 Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and...

Jul 15, 2013, 15:12 ET

Oligomerix, Inc. Announces Addition of Industry Veteran James Hendrix, Ph.D., to Serve as Senior Director of Chemistry

 Oligomerix, Inc., a privately held company pioneering the discovery and development of disease modifying therapeutics for Alzheimer's disease...

Jul 08, 2013, 14:38 ET

Oligomerix, Inc. to Present Multiple Posters Highlighting its Tau-Focused Technology During the Annual Alzheimer's Association International Conference®

 Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and...

May 22, 2013, 10:17 ET

Oligomerix, Inc. Completes Series B Financing

 Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and...

Apr 23, 2012, 08:02 ET

Oligomerix, Inc. Completes $2 Million Series A Financing

Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related...

Nov 16, 2011, 17:40 ET

A New Mechanism for Tau Protein Pathology in Alzheimer's Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting

Oligomerix, Inc. presented results at the Society for Neuroscience meeting in Washington D.C. which demonstrated that tau protein forms neurotoxic...

Nov 11, 2010, 10:17 ET

Oligomerix, Inc. Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer's Disease

Oligomerix, Inc. today announced the receipt of a two-year Small Business Innovation Research (SBIR) Phase II grant for $1.6M from the National...

Oct 13, 2010, 10:17 ET

OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer

OLIGOMERIX, Inc. announced today that Vic Micati, a Director since 2007, has been appointed Chairman of Oligomerix and that Jack Pasini has been...

Feb 25, 2009, 10:17 ET

OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer's Disease

OLIGOMERIX, Inc. today announced the receipt of a Small Business Innovation Research (SBIR) Phase I grant for $323,000 from the National Institute...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge